Cargando…
Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475331/ https://www.ncbi.nlm.nih.gov/pubmed/26091916 http://dx.doi.org/10.1186/s13075-015-0680-8 |
| _version_ | 1782377450647322624 |
|---|---|
| author | Vastesaeger, Nathan Fautrel, Bruno Smolen, Josef |
| author_facet | Vastesaeger, Nathan Fautrel, Bruno Smolen, Josef |
| author_sort | Vastesaeger, Nathan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4475331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44753312015-06-21 Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ Vastesaeger, Nathan Fautrel, Bruno Smolen, Josef Arthritis Res Ther Letter BioMed Central 2015-06-20 2015 /pmc/articles/PMC4475331/ /pubmed/26091916 http://dx.doi.org/10.1186/s13075-015-0680-8 Text en © Vastesaeger et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Vastesaeger, Nathan Fautrel, Bruno Smolen, Josef Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title_full | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title_fullStr | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title_full_unstemmed | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title_short | Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| title_sort | response to ‘feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475331/ https://www.ncbi.nlm.nih.gov/pubmed/26091916 http://dx.doi.org/10.1186/s13075-015-0680-8 |
| work_keys_str_mv | AT vastesaegernathan responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritis AT fautrelbruno responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritis AT smolenjosef responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritis |